Jun 27, 2025

According to our new research study on "Medical Writing Market Forecast to 2031 -Global Analysis - by Type, Application, and End User," the market is anticipated to grow from US$ 3,931.50 million in 2023 and is projected to reach US$ 9,114.91 million by 2031; it is expected to register a CAGR of 11.1% during 2023-2031. The medical writing market growth is attributed to the growing importance of medical writing to obtain approval from regulatory authorities and a high preference for CROs. Medical writing involves creating clear, accurate, and well-structured content related to healthcare, medicine, and life sciences. This can encompass a wide variety of materials, including research papers, regulatory documents, clinical trial reports, educational content, and promotional materials for pharmaceutical products. North America accounted for a major share of the global medical writing market in 2023. The North America medical writing market is segmented into the US, Canada, and Mexico. Increasing regulatory requirements, a growing number of clinical trials, and the expanding pharmaceutical and biotech sectors. Stricter compliance standards from regulatory bodies such as the United States Food and Drug Administration (US FDA) also contribute to the demand for accurate medical documentation. Additionally, the trend of outsourcing medical writing tasks further boosts market growth. In North America, the US is the largest market for medical writing. In the US, The US medical writing market is driven by regulatory demands, clinical trial growth, and expansion of pharmaceutical and biotech industries. - Regulatory Demands: With increased drug approvals, such as the 55 new drugs approved by the Center for Drug Evaluation and Research (CDER) in 2023, the need for precise regulatory documentation has surged. Medical writers play a crucial role in preparing clinical study reports, regulatory submissions, and other compliance documents. - Clinical Trials Growth: The US is a major hub for clinical trials, particularly in oncology, rare diseases, and immunology. The growing number of trials drives the need for medical writers to support trial protocols, regulatory filings, and clinical reports. - Pharma & Biotech Expansion: The US is home to leading pharmaceutical companies such as Pfizer, Johnson & Johnson, and Merck, fueling the demand for regulatory submissions, clinical trial reports, and product labeling, in turn expanding the medical writing market. IQVIA, Parexel, Syneos Health, and Covance are among the key players operating in the market. Market players adopt inorganic growth strategies for market expansion. For instance, Parexel, one of the largest clinical research organizations (CROs) in the world, offers a comprehensive range of clinical development services from Phase I to IV. They have partnered with Palantir Technologies Inc., a leader in building Artificial Intelligence (AI) systems, to create a multi-year strategic alliance aimed at enhancing and accelerating the delivery of safe and effective clinical trials for biopharmaceutical clients. Through this collaboration, Parexel will utilize Palantir"s Foundry and Artificial Intelligence Platform (AIP) to enhance its clinical data platform, focusing on increasing the efficiency of clinical trials while ensuring the highest standards of safety and regulatory compliance. Implementation of Tools and Artificial Intelligence in Medical Writing to Provide Market Opportunities in Future The work burden of medical writers can be effectively handled with the use of AI tools that can help automate the document review and verification process. Numerous new tools are being implemented internally and at the sponsor level. For instance, online medical dictionaries such as Taber's Cyclopedic Medical Dictionary and Stedman's Medical Dictionary are developed for medical students, physicians, researchers, and medical language specialists. They include medical terms, abbreviations, acronyms, and measurements for assistance and reference. Medical writers working in regulatory settings use standardized templates for the documents they create. Recently, Cognizant and Yseop collaborated to accelerate the delivery of scientific content in the biopharmaceutical industry through generative AI. By utilizing Yseop Copilot, medical writers working with life sciences companies can reduce writing time and enhance consistency and productivity of reports in record time. Artificial intelligence is intended to eliminate the work involved in creating certain regulatory documents along with allowing medical writers to devote their attention to more engaging aspects of document creation and contribute the market growth in coming years. Medical Writing Market: Competitive Landscape and Key Developments Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences are among the key companies operating in the medical writing market. The National Center for Biotechnology Information, The International Union of Basic and Clinical Pharmacology (IUPHAR), and Investor Presentations are among the primary and secondary sources referred to while preparing the medical writing market report.